Title of article
Long-term effects of Aβ42 immunisation in Alzheimerʹs disease: follow-up of a randomised, placebo-controlled phase I trial
Author/Authors
Clive Holmes، نويسنده , , Delphine Boche، نويسنده , , David Wilkinson، نويسنده , , Ghasem Yadegarfar، نويسنده , , Vivienne Hopkins، نويسنده , , Anthony Bayer، نويسنده , , Roy W Jones، نويسنده , , Roger Bullock، نويسنده , , Seth Love، نويسنده , , James G. Neal، نويسنده , , Elina Zotova، نويسنده , , James AR Nicoll، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
216
To page
223
Abstract
Summary
Background
Immunisation of patients with Alzheimerʹs disease with full-length amyloid-β peptide (Aβ42) can clear amyloid plaques from the brain. Our aim was to assess the relation between Aβ42 immune response, degree of plaque removal, and long-te
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
593192
Link To Document